 Home > Medical News > Latest Medical News > Pfizer sells mid-term TYK2 inflammation drugs or withdraws from competition with Bristol-Myers Squibb

Pfizer sells mid-term TYK2 inflammation drugs or withdraws from competition with Bristol-Myers Squibb

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

start company

fda drug list

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationTom Lee

Recently, news has shown that Pfizer seems to be withdrawing from the competition in the TYK2 inhibitor market

Competitors, Bristol Myers Squibb (Bristol Myers Squibb) has made leading progress in the field of TYK2, bringing the candidate drug deucvacitinib through clinical testing.

However, Pfizer recently revealed that it is considering selling TYK2 assets

Brepocitinib (PF-06700841) is an oral tyrosine kinase 2 (TYK2)/JAK1 inhibitor

SVB Leerink analysts have previously stated that Pfizer’s brepocitinib is difficult to beat deucravacitinib’s Phase II performance, and that the company is about two years behind Bristol Myers’ progress in this area

In the context of the JAK inhibitor FDA issued a series of safety warnings and questioning, the CEO said that Pfizer still believed in the importance of such drugs "for patients with appropriate inflammatory illness"

Reference source: Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.